‘Risk of explosion’: Hair mousse sold in a dozen states recalled: FDA
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"‘Risk of explosion’: Hair mousse sold in a dozen states recalled: FDA" is generating significant coverage in the Business category, with 7 articles from 7 distinct sources tracked by PULSE so far.
Outlets currently covering the story include facebook.com, Yahoo, the-sun.com and Boston 25 News. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 95d ago.
Quick answers
Why is "‘Risk of explosion’: Hair mousse sold in a dozen states recalled: FDA" trending?
Because 7 independent news sources published 7 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (7)
- The recalled product is sold in 6.76-ounce aluminium bottles across 12 states, including Florida, Ohio, Pennsylvania, South Carolina and Washington. facebook.com · 97d ago
- Henkel recalls Schwarzkopf hair mousse over explosion risk Yahoo · 97d ago
- FDA recalls popular hair product sold in 12 states over fears it could EXPLODE the-sun.com · 97d ago
- Recall alert: Schwarzkopf Professional Osis Grip hair cans recalled over packaging issue Boston 25 News · 97d ago
- Hair mousse recalled over explosion risk. See affected product USA Today · 97d ago
- Hair product recalled in Pennsylvania due to explosion risk ABC27 · 97d ago
- ‘Risk of explosion’: Hair mousse sold in a dozen states recalled: FDA FOX 8 News · 97d ago
Topics
Related trends
Roche Secures First U.S. Approval for New Breast-Cancer Pill
Roche wins FDA approval for its first U.S. oral SERD, giredestrant plus everolimus, for hormone-resistant advanced breast cancer.
Novo says Wegovy injection lowers BMI and obesity rates in children in trial
Novo Nordisk reports Wegovy injection reduced BMI and obesity rates in children as young as six in a clinical trial, expanding the drug's potential pediatric use.
The GLP-1 boom has a dark side
FDA orders new eye-risk warnings on a dozen GLP-1 drugs, including Ozempic and Zepbound, amid reports of vision-threatening events.
Millions of Americans are not taking their GLP-1 drugs as prescribed
Nearly half of U.S. GLP-1 users are altering prescribed dosing, with cost and side effects driving widespread non-adherence.
FDA rejects Summit’s ivonescimab, derailing US arrival of much-hyped PD-1xVEGF class
The United States Food and Drug Administration has rejected Summit Therapeutics and Akeso's lung cancer drug ivonescimab.
EXCLUSIVE: US FDA shelves commissioner's voucher program for speedy drug reviews, sources say
The US FDA has shelved its commissioner's priority review voucher pilot program for expedited drug reviews, according to exclusive reporting from Reuters and coverage across multiple outlets.